Anavex Life Sciences Corp.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 12X1.F | NMRA | TNXP | GANX | ABVC | VYGR | |
|---|---|---|---|---|---|---|
| Market cap | 92.97M | 106.35M | 87.64M | 48.44M | 26.69M | 115.23M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -1.5 | -0.9 | -0.7 | -1.6 | -2.3 | -1.5 |
| Price/book | 0.9 | 2.4 | 0.4 | 4.3 | 2.5 | 0.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −84.50% | −78.06% | −71.36% | −41.58% | −64.79% | −55.69% |
| Today | −2.05% | −0.86% | −1.54% | −3.48% | +1.51% | +2.19% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All 12X1.F news ›DEADLINE ALERT for Fluence Energy, Inc. (FLNC), Qfin Holdings, Inc. (QFIN), Endava plc (DAVA), and Anavex Life Sciences Corp. (AVXL): The Law Offices of Frank R. Cruz Reminds Investors of Lead Plaintiff Deadlines in Securities Fraud Class Actions
LOS ANGELES, Nov. 03, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors of upcoming lead plaintiff deadlines in securities class action lawsuits filed on behalf of shareholders of Fluence Energy, Inc., Qfin…
Anavex Life Sciences Names Terrie Kellmeyer, Ph.D., as President and Chief Executive Officer and Member of the Board of Directors
Anavex Life Sciences Anavex Life Sciences Names Terrie Kellmeyer, Ph.D., as President and Chief Executive Officer and Member of the Board of Directors Seasoned biopharma
Anavex Life Sciences appoints Terrie Kellmeyer as CEO
Anavex Life Sciences names Terrie Kellmeyer CEO and board member, signaling leadership continuity. - Anavex Life Sciences (AVXL) on Tuesday appointed Terrie Kellmeyer as President and Chief Executive Officer. - Kellmeyer, who had been…
More from 1 other outlet
Anavex Life Sciences Corp. Investors Seeking Lead Plaintiff Role Have Until November 30th to Contact Bragar Eagel & Squire, P.C.
November 03, 2026 17:57 ET | Source: Bragar Eagel & Squire Bragar Eagel & Squire Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Anavex (AVXL) To Contact Him Directly To Discuss…
Anavex Life Sciences Sees Three Board Members Resign Amid Strategic Disagreements, Board Committees Reshaped
Kalkine Media On November 2, 2026, Anavex Life Sciences Corp. announced via a Form 8-K the simultaneous resignation of three directors on October 28, 2026, each citing differences over the co
SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Anavex Life Sciences Corp. (NASDAQ: AVXL) — Investors Who Suffered Losses Are Encouraged to Contact the Firm
Nationally Recognized Firm Urges Anavex Investors to Explore Class Action Representation Lead Plaintiff Deadline: November 30, 2026. Investors who purchased (NASDAQ: AVXL) securities between November 26, 2025 and August 28, 2026 may be…
More from 2 other outlets
- The National Law Review AVXL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Anavex Life Sciences Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- ACCESSWIRE Newsroom AVXL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Anavex Life Sciences Corp. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
ANAVEX DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Anavex Life Sciences Corp. Investors ...
Black Hills Pioneer NEW YORK, Oct. 31, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) be
Kirby McInerney LLP Alerts Investors Who Acquired Anavex Life Sciences Corp. AVXL Securities Between November 26, 2025 and August 28, 2026 of Pending Lawsuit
October 29, 2026 18:00 ET | Source: Kirby McInerney LLP Kirby McInerney LLP What is the Lead Plaintiff Deadline? Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the…
Anavex Deadline: AVXL Investors with Losses in Excess of $100K Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit Filed by The Rosen Law Firm
/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between... NEW YORK, Oct. 31, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor…
What's Next for Anavex Life Sciences Corp. Shareholders After 6.35% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline
Complaint alleges Anavex Life Sciences Corp. misled investors between November 26, 2025 and August 28, 2026; investors may seek lead plaintiff role by November 30, 2026 Investors who suffered losses on Anavex Life Sciences Corp.…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- globenewswire.com18
- prnewswire.com15
- newsfilecorp.com10
- natlawreview.com6
- accessnewswire.com5
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 82 articles, not a forecast.